
Our Laboratory and Clinical Trials teams, based in Cypress, California, (Focus Diagnostics) have met the expanding demands of pharmaceutical and biotechnology companies for nearly two decades. During the 2009 H1N1 pandemic, we worked closely with public health professionals across the globe, to develop laboratory tests to help respond to urgent vaccine development and efficacy needs emerging outside the normal course of seasonal influenza
Our unrivaled expertise and capabilities support:
Our expertise, response time and highly personalized service make partnering with Quest Diagnostics for the provision of laboratory testing services related to your vaccine development programs the right solution for your business.
When a broader scope of laboratory testing is needed, our team can provide our clients with access to Quest Diagnostics' extensive global capabilities for clinical trials. We have the resources and flexibility to meet our clients' needs for any study, regardless of the study's size, by providing the customization they require.
Custom assay development and validation*
*Additionally, we offer qualification and validation for client-defined assays.
Standardized with WHO and CDC reference methods
Proficiency in Vaccine Response Studies
Routine use of highly specialized 'gold standard' methods that are technically difficult to perform and reproduce. Examples:
| Pathogen / Vaccine | Testing Method |
|---|---|
| Smallpox virus | Microneutralization |
| Japanese encephalitis virus, Yellow Fever | PRNT |
| Influenza virus | Hemagglutination inhibition, microneutralization |
| Poliovirus | Viral neutralization |
| West Nile virus | PRNT |
| St. Louis encephalitis virus | PRNT |
| Dengue virus | FRNT/PRNT |
Quest, Quest Diagnostics, the associated logo, Nichols Institute and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics.
All third-party marks- ® - are the property of their respective owners. © 2000-2010 Quest Diagnostics Incorporated. All rights reserved.